These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


293 related items for PubMed ID: 15709031

  • 1. Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue.
    Gillgrass AE, Tang VA, Towarnicki KM, Rosenthal KL, Kaushic C.
    J Virol; 2005 Mar; 79(5):3117-26. PubMed ID: 15709031
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation.
    Gillgrass AE, Fernandez SA, Rosenthal KL, Kaushic C.
    J Virol; 2005 Mar; 79(5):3107-16. PubMed ID: 15709030
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
    Parr MB, Kepple L, McDermott MR, Drew MD, Bozzola JJ, Parr EL.
    Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
    [Abstract] [Full Text] [Related]

  • 9. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.
    Wizel B, Persson J, Thörn K, Nagy E, Harandi AM.
    Vaccine; 2012 Jun 19; 30(29):4361-8. PubMed ID: 22682292
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of genital T cell responses to herpes simplex virus type 2 resulting from immunization of the nasal mucosa.
    Milligan GN, Dudley-McClain KL, Chu CF, Young CG.
    Virology; 2004 Jan 20; 318(2):507-15. PubMed ID: 14972519
    [Abstract] [Full Text] [Related]

  • 12. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
    Tengvall S, O'Hagan D, Harandi AM.
    Antiviral Res; 2008 Jun 20; 78(3):202-14. PubMed ID: 18276020
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
    Gill N, Deacon PM, Lichty B, Mossman KL, Ashkar AA.
    J Virol; 2006 Oct 20; 80(20):9943-50. PubMed ID: 17005672
    [Abstract] [Full Text] [Related]

  • 19. Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2.
    Parr EL, Parr MB.
    J Virol; 1997 Nov 20; 71(11):8109-15. PubMed ID: 9343160
    [Abstract] [Full Text] [Related]

  • 20. Immunity to vaginal HSV-2 infection in immunoglobulin A knockout mice.
    Parr MB, Harriman GR, Parr EL.
    Immunology; 1998 Oct 20; 95(2):208-13. PubMed ID: 9824477
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.